TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
EMM Life Science AB
Closing information (x1000 EUR)
Closing information | 2024/08 | 2023/08 | 2022/08 |
Turnover |
2,304
|
2,595 | |
Financial expenses |
0
![]() |
0 | |
Earnings before taxes |
367
|
197 | |
EBITDA |
183
|
204 | |
Total assets |
557
|
1,902 | |
Current assets |
549
|
1,029 | |
Current liabilities |
238
|
372 | |
Equity capital |
319
|
1,529 | |
- share capital |
8
|
9 | |
Employees (average) |
4
|
2
![]() |
2 |
Financial ratios
Fiscal year | 2024/08 | 2023/08 | 2022/08 |
Solvency |
57.3%
|
80.4% | |
Turnover per employee |
1,152
|
1,298 | |
Profit as a percentage of turnover |
15.9%
|
7.6% | |
Return on assets (ROA) |
65.9%
|
10.4% | |
Current ratio |
230.7%
|
276.6% | |
Return on equity (ROE) |
115.0%
|
12.9% | |
Change turnover |
-37
|
762 | |
Change turnover % |
18%
|
-2%
|
42% |
Chg. No. of employees |
2
|
0
![]() |
0 |
Chg. No. of employees % |
100%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/08 | 2023/08 | 2022/08 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.